Skip to content
HowShorted

How shorted is Pyxis Oncology, Inc.? PYXS

#1,490most shorted US stockof 3,805 ranked stocks, more shorted than 60%

5.61%
of shares outstanding reported short ยท settlement date 15 Sep 2026
vs previous report
+0.85
5 reports (~10 weeks)
+1.97
days to cover
3.65
Aggregate net short position time series for Pyxis Oncology, Inc.

Markers along the chart's base: โ–ฒ results announced (an 8-K reporting results was filed) โ–ฒ quarterly or annual report filed. Dates are SEC filing dates; hover a point to see events since the previous settlement.

Days to cover

FINRA's own figure: reported shares short divided by the stock's average daily trading volume, published alongside each settlement. It expresses the short position in days of typical trading rather than as a percentage of the company; the two can move differently.

Aggregate net short position time series for Pyxis Oncology, Inc. days to cover

Short interest around results

For each results announcement (an 8-K reporting results, by its SEC filing date), the FINRA settlement before it and the first one after. Settlements fall twice a month, so the two figures can sit up to a month apart and much else changes in between: this shows what was reported, not why.

Reported short interest before and after each results announcement
Results filedSettlement beforeSettlement afterChange
13 Aug 20266.64% 31 Jul 20265.31% 14 Aug 2026โˆ’1.33
14 May 20263.16% 30 Apr 20262.88% 15 May 2026โˆ’0.28
23 Mar 20264.00% 13 Mar 20264.24% 31 Mar 2026+0.24
3 Nov 20257.00% 31 Oct 20257.29% 14 Nov 2025+0.29
14 Aug 20257.62% 31 Jul 20258.11% 15 Aug 2025+0.49
15 May 202511.75% 30 Apr 202510.51% 30 May 2025โˆ’1.24
18 Mar 202511.64% 14 Mar 202511.91% 31 Mar 2025+0.27
12 Nov 20249.93% 31 Oct 20249.82% 15 Nov 2024โˆ’0.11

Fails to deliver

The SEC's fails-to-deliver figure for PYXS: the aggregate net balance of shares that failed to be delivered at each settlement date, published by the SEC twice a month and shown here verbatim for the trailing window. A balance is not a daily flow, and a fail has many ordinary causes; the SEC says it cannot guarantee the accuracy of the data. See what fails to deliver are and the largest balances today.

Last balance on file
15,104
11 Sep 2026
Highest in window
105,832
19 Dec 2025
Days with a balance
74
Window
16 Sep 2025 to 14 Sep 2026
Aggregate net short position time series for Pyxis Oncology, Inc. fails to deliver

Source: U.S. Securities and Exchange Commission, fails-to-deliver data (public domain). Only settlement days with a positive balance appear; the largest balance in the window was 106K shares.

Embed this chart

Paste this snippet to embed the interactive chart. It updates with each FINRA report and keeps the source attribution. Preview

Download chart cardShare on XRedditLinkedIn
Cite this page
Plain
Wikipedia
BibTeX

Sector: Healthcare

History

Full reported short interest history
Settlement dateShort %Change
15 Sep 20265.61%+0.85
31 Aug 20264.76%โˆ’0.55
14 Aug 20265.31%โˆ’1.33
31 Jul 20266.64%+1.46
15 Jul 20265.18%+1.54
30 Jun 20263.64%+0.43
15 Jun 20263.21%+0.44
29 May 20262.77%โˆ’0.11
15 May 20262.88%โˆ’0.28
30 Apr 20263.16%โˆ’0.45
15 Apr 20263.61%โˆ’0.63
31 Mar 20264.24%+0.24
13 Mar 20264.00%โˆ’0.06
27 Feb 20264.06%+0.14
13 Feb 20263.92%+0.09
30 Jan 20263.83%+0.12
15 Jan 20263.71%+0.93
31 Dec 20252.78%โˆ’0.32
15 Dec 20253.10%โˆ’4.17
28 Nov 20257.27%โˆ’0.02
14 Nov 20257.29%+0.29
31 Oct 20257.00%+0.15
15 Oct 20256.85%+0.19
30 Sep 20256.66%โˆ’0.37
15 Sep 20257.03%+0.04
29 Aug 20256.99%โˆ’1.12
15 Aug 20258.11%+0.49
31 Jul 20257.62%โˆ’0.14
15 Jul 20257.76%โˆ’0.46
30 Jun 20258.22%โˆ’1.81
13 Jun 202510.03%โˆ’0.48
30 May 202510.51%โˆ’0.93
15 May 202511.44%โˆ’0.31
30 Apr 202511.75%+0.17
15 Apr 202511.58%โˆ’0.33
31 Mar 202511.91%+0.27
14 Mar 202511.64%โˆ’0.15
28 Feb 202511.79%+0.23
14 Feb 202511.56%โˆ’0.22
31 Jan 202511.78%โˆ’0.71
15 Jan 202512.49%+0.15
31 Dec 202412.34%+1.58
13 Dec 202410.76%+0.53
29 Nov 202410.23%+0.41
15 Nov 20249.82%โˆ’0.11
31 Oct 20249.93%+1.60
15 Oct 20248.33%+1.16
30 Sep 20247.17%+0.78
13 Sep 20246.39%โˆ’0.07
30 Aug 20246.46%โˆ’0.35
15 Aug 20246.81%โˆ’0.06
31 Jul 20246.87%+0.82
15 Jul 20246.05%+2.07
28 Jun 20243.98%+0.01
14 Jun 20243.97%+0.20
31 May 20243.77%+0.39
15 May 20243.38%+0.20
30 Apr 20243.18%โˆ’0.62
15 Apr 20243.80%โˆ’0.85
28 Mar 20244.65%+0.96
15 Mar 20243.69%+0.67
29 Feb 20243.02%+0.14
15 Feb 20242.88%+1.11
31 Jan 20241.77%+0.39
12 Jan 20241.38%โˆ’0.05
29 Dec 20231.43%โˆ’0.09
15 Dec 20231.52%โˆ’0.16
30 Nov 20231.68%โˆ’0.13
15 Nov 20231.81%โˆ’0.19
31 Oct 20232.00%โˆ’0.22
13 Oct 20232.22%โˆ’0.16
29 Sep 20232.38%+0.08
15 Sep 20232.30%โˆ’0.13
31 Aug 20232.43%โˆ’0.44
15 Aug 20232.87%โˆ’5.36
30 Jun 20238.23%โˆ’0.28
15 Jun 20238.51%0.00
31 May 20238.51%+0.20
15 May 20238.31%โˆ’1.42
28 Apr 20239.73%โˆ’3.03
14 Apr 202312.76%โˆ’0.35
31 Mar 202313.11%+10.34
31 Jan 20232.77%+0.07
13 Jan 20232.70%+0.35
30 Dec 20222.35%+0.61
15 Dec 20221.74%+0.91
30 Nov 20220.83%+0.37
15 Nov 20220.46%โˆ’0.90
15 Jun 20221.36%โˆ’0.10
31 May 20221.46%+0.40
13 May 20221.06%+0.02
29 Apr 20221.04%โˆ’0.24
14 Apr 20221.28%โˆ’0.36
31 Mar 20221.64%+0.17
15 Mar 20221.47%+0.01
28 Feb 20221.46%โˆ’0.03
15 Feb 20221.49%+0.09
31 Jan 20221.40%+0.30
14 Jan 20221.10%โ€“

Newest first. Scroll inside the table for earlier dates, back to 14 Jan 2022.

Frequently asked questions

How shorted is Pyxis Oncology, Inc. right now?
5.61% of Pyxis Oncology, Inc.'s (PYXS) shares outstanding were reported short for settlement date 15 Sep 2026, per FINRA's consolidated short interest report. That makes it the 1,490th most shorted US stock, out of 3,805 we rank.
What does this number include?
FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.
Why does it only update twice a month?
US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.
Is this PYXS's short float?
No. This is short interest as a percentage of shares outstanding, the count in the company's SEC filings. "Short float" divides the same FINRA short count by the public float, which excludes closely held shares, so it comes out higher for the same company. We publish no float estimates: the float is not a regulatory figure.
What is PYXS's days to cover?
3.65 days for settlement date 15 Sep 2026: FINRA's own short interest ratio, the reported shares short divided by average daily trading volume. It is published in the same FINRA file and shown verbatim; we hold no volume data ourselves.
Which funds are short?
US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.